MMP-9, MMP-2, VEGF and VEGFR-2 as Factors of Invasion and Angiogenesis in Squamous Cell Carcinoma of the Cervix
-
Published:2022
Issue:4
Volume:5
Page:e00187
-
ISSN:2618-7531
-
Container-title:Biomedical Chemistry: Research and Methods
-
language:en
-
Short-container-title:BMCRM
Author:
Timoshenko O.S.1, Kugaevskaya E.V.1, Gureeva T.A.1
Affiliation:
1. Institute of Biomedical Chemistry, Moscow, Russia
Abstract
Tissue destruction and angiogenesis play an important role in malignant tumor progression. They are responsible for the tumor growth and progress and its ability to invade and metastasize. The key role in the destructive processes belongs to matrix metalloproteinases (MMPs), which are able to cleave almost all components of the extracellular matrix (ECM). Gelatinases MMP-2 and MMP-9 hydrolyze type IV collagen, the main component of basement membranes, thereby releasing various biologically active molecules from ECM, including vascular endothelial growth factor (VEGF). VEGF is a key regulator of angiogenesis. The main mediator of the biological action of VEGF is its receptor VEGFR2. This study was aimed at assessing the relationship between the expression of the main factors of tissue destruction and angiogenesis - MMP-2, MMP-9, VEGF and VEGFR2 in the early and later stages of cervical squamous cell carcinoma (CSCC). The work was performed using samples of tumor and surrounding morphologically normal tissue, obtained from patients with or without metastases to regional lymph nodes. We have shown that MMP- 9 is significantly expressed in tumors in CSCC already at the early stages of tumor progression. At later stages of the disease (when metastases to regional lymph nodes are detected in patients), the expression of MMP-2, VEGF and VEGFR2 increases markedly both in the tumor and in the morphologically normal tissue surrounding the tumor and makes an additional contribution to the processes of destruction, angiogenesis and metastasis. We assume that MMP-2, VEGF and VEGFR2 can be considered as negative markers of the course of CSCC.
Publisher
Institute of Biochemistry
Reference36 articles.
1. Wyganowska-?wi?tkowska, M., Tarnowski, M., Murtagh, D., Skrzypczak-Jankun, E., Jankun, J. (2019) Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review). Int. J. Mol. Med., 43(1), 15-25. 2. Cabral-Pacheco, G.A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acu�a, J.M., Perez-Romero, B.A., Guerrero-Rodriguez, J.F., Martinez-Avil, N., Martinez-Fierro, M.L. (2020) The roles of matrix metalloproteinases and their Inhibitors in human diseases. Int. J. Mol. Sci., 21(24), 9739. 3. Kapoor, C., Vaidya, S., Wadhwan, V., Kaur, G., Pathak, A. (2016) Seesaw of matrix metalloproteinases (MMPs). J. Cancer Res. Ther., 12(1), 28-35. 4. Laronha, H., Caldeira, J. (2020) Structure and function of human matrix metalloproteinases. Cells, 9(5), 1076. 5. Gialeli, C., Theocharis, A.D., Karamanos, N.K. (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J., 278(1), 16-27.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|